| Author |
Title |
Year |
Publication |
Volume |
Pages  |
| Heffernan, J.M.; McNamara, J.B.; Borwege, S.; Vernon, B.L.; Sanai, N.; Mehta, S.; Sirianni, R.W. |
PNIPAAm-co-Jeffamine(R) (PNJ) scaffolds as in vitro models for niche enrichment of glioblastoma stem-like cells |
2017 |
Biomaterials |
143 |
149-158 |
| Li, M.; Zhao, H.; Ananiev, G.E.; Musser, M.T.; Ness, K.H.; Maglaque, D.L.; Saha, K.; Bhattacharyya, A.; Zhao, X. |
Establishment of Reporter Lines for Detecting Fragile X Mental Retardation (FMR1) Gene Reactivation in Human Neural Cells |
2017 |
Stem Cells (Dayton, Ohio) |
35 |
158-169 |
| Tahara, T.; Hirata, I.; Nakano, N.; Nagasaka, M.; Nakagawa, Y.; Shibata, T.; Ohmiya, N. |
Comprehensive DNA Methylation Profiling of Inflammatory Mucosa in Ulcerative Colitis |
2017 |
Inflammatory Bowel Diseases |
23 |
165-173 |
| Glaser, T.; Han, I.; Wu, L.; Zeng, X. |
Targeted Nanotechnology in Glioblastoma Multiforme |
2017 |
Frontiers in Pharmacology |
8 |
166 |
| Jensen, S.S.; Petterson, S.A.; Halle, B.; Aaberg-Jessen, C.; Kristensen, B.W. |
Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo |
2017 |
BMC Cancer |
17 |
178 |
